Literature DB >> 20791423

Failure of a Relatively Small Dose of Passively Administered Anti-Rh to Suppress Primary Immunization by a Relatively Large Dose of Rh-positive Red Cells.

N C Hughes-Jones, P L Mollison.   

Abstract

Year:  1968        PMID： 20791423      PMCID： PMC1984593          DOI： 10.1136/bmj.1.5585.150

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore.

Authors: 
Journal:  Br Med J       Date:  1966-10-15

2.  The estimation of the concentration and equilibrium constant of anti-D.

Authors:  N C Hughes-Jones
Journal:  Immunology       Date:  1967-05       Impact factor: 7.397
  2 in total
  8 in total

1.  Immunosuppressive therapy in Rh-incompatible transfusion.

Authors:  J Eklund; H R Nevanlinna
Journal:  Br Med J       Date:  1971-09-11

2.  Prevention of rhesus immunization. A controlled clinical trial with a comparatively low dose of anti-D immunoglobulin.

Authors:  C Dudok de Wit; E Borst-Eilers; C M Weerdt; G J Kloosterman
Journal:  Br Med J       Date:  1968-11-23

3.  Aspects of Rh incompatibility.

Authors: 
Journal:  Can Med Assoc J       Date:  1968-09-07       Impact factor: 8.262

Review 4.  Immunology of pregnancy: significance of blood group incompatibility between mother and foetus.

Authors:  C A Clarke
Journal:  Proc R Soc Med       Date:  1968-11

5.  Anti-Rh immune globulin: how should we use it?

Authors:  P G Hattersley
Journal:  Calif Med       Date:  1969-02

6.  The multiple use of RhoGAM.

Authors:  L Keith; M Halloway; R C Stepto
Journal:  J Natl Med Assoc       Date:  1973-01       Impact factor: 1.798

7.  Treatment of mismatched transfusions in Rh-negative women with anti-D plasma.

Authors:  L L de Veber
Journal:  Can Med Assoc J       Date:  1968-09-07       Impact factor: 8.262

8.  Clinical evaluation of Rho(D) immune globulin (human) in Canada.

Authors:  E C Bryant; G D Hart; D Cairns; J A Gamarra; L L de Veber; C G Holland; J L Hutchison
Journal:  Can Med Assoc J       Date:  1969-12-13       Impact factor: 8.262
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.